Asset Class
Equities Research Hub
Global equity markets are currently navigating a 'risk-off' environment characterized by a significant rotation from technology to defensive sectors. This shift is highlighted by a sharp 5.9% decline in the US Momentum factor and a correction in US tech stocks, even as companies like Alphabet continue massive investments in AI infrastructure. Earnings reports for 4Q25 reveal a mixed landscape; while consumer names like Yum! Brands show resilience, sector-specific pressures such as multiple compression for Ferrari and disappointing guidance from Information Services firm Gartner have led to price target downward revisions. In Europe, pharmaceutical giants GSK and Novartis have issued guidance trailing consensus, further contributing to a cautious outlook in the region. Regional equity sentiment is also being shaped by political developments, most notably in Japan, where a projected LDP victory is expected to support 'Abenomics'-style stimulus alongside Bank of Japan rate hikes totaling 75bp. Additionally, the cooling of Brent crude prices toward $68/b amid diplomatic progress in the Middle East and large-scale renewable energy investments, such as Saudi Arabia's $2bn solar agreement with Turkey, are influencing broader market dynamics. Despite localized volatility and currency fluctuations, global PMIs suggest an underlying 2.8% annualized rise in GDP, providing a macro cushion for diversified equity portfolios.
2984 reports available
All reports
Page 18 of 125
Research Unplugged: Data Centers and Behind the Meter Solutions
Goldman Sachs · Jun 9, 2026
GS TMT Spec Sales
Goldman Sachs · Jun 9, 2026
United Kingdom Retail Supermarkets
Goldman Sachs · Jun 9, 2026
GS Morning Market Update
Goldman Sachs · Jun 9, 2026
Up And Adam
Raymond James · Jun 9, 2026
New Zealand Morning Focus
ANZ · Jun 9, 2026
Shoring Up The Indian Rupee – RBI June 2026 Measures
MUFG · Jun 9, 2026
Update on Leo and Satellite Connectivity
Barclays · Jun 9, 2026
Global Macro Insights
Franklin Templeton · Jun 9, 2026
AI Capex Funding: Why Equity? Why Converts?
Barclays · Jun 9, 2026
AI’s Next Phase From Capital Spending To Capital Returns
Nuveen · Jun 9, 2026
Midday Market Intelligence
Goldman Sachs · Jun 9, 2026
Recombinant DNA: 250 Years of US Innovation
UBS Financial Services Inc. · Jun 9, 2026
Derivatives Strategy
UBS · Jun 9, 2026
Kiniksa Pharmaceuticals Key Takeaways
Goldman Sachs · Jun 9, 2026
Market Rhythm
EFG Bank AG · Jun 9, 2026
The Kevin Warsh Fed
TS Lombard · Jun 9, 2026
Blue Owl Capital: 5 Takeaways From Dinner With Co-CEO & CFO
Bank of America · Jun 9, 2026
Daily Europe
UBS · Jun 9, 2026
Chinese Capital Returns To Australia
Deutsche Bank · Jun 9, 2026
The Point For Latin America
Citi · Jun 9, 2026
Health Care Offers More Than a Defensive Role in Portfolios
UBS · Jun 9, 2026
Oracle Corporation 4Q26 Preview
Bank of America · Jun 9, 2026
Markets Today
Bank of New Zealand · Jun 9, 2026